Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (451-460 of 625) with videos related to

Pageof 63
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2018
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor InhibitorsAtul Deodhar, Denis Poddubnyy, Cesar Pacheco-Tena, et al.
The New England Journal of Medicine|July 27, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Plos One|January 26, 2022
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysisGiulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Rheumatology (Oxford, England)|September 22, 2021
Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trialsMark C Genovese, Eduardo Mysler, Tetsuya Tomita, et al.
Annals of the Rheumatic Diseases|March 10, 2022
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialMaria C Cid, Sebastian H Unizony, Daniel Blockmans, et al.
Journal of Clinical Medicine|June 2, 2021
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological TherapyElena Bolletta, Marco Coassin, Danilo Iannetta, et al.
Journal of Personalized Medicine|December 23, 2022
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast StudyChrystel Isca, Amelia Spinella, Angela Toss, et al.
Ocular Immunology and Inflammation|October 5, 2020
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular SarcoidosisElena Bolletta, Valentina Mastrofilippo, Alessandro Invernizzi, et al.
Rheumatology (Oxford, England)|May 26, 2020
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trialsMark C Genovese, Eduardo Mysler, Tetsuya Tomita, et al.
Frontiers in Oncology|November 7, 2022
Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL studySerena Di Cosimo, Maria Teresa Lupo-Stanghellini, Massimo Costantini, et al.
Pageof 63

Showing results (451-460 of 625) with videos related to

Sort By:
Pageof 63
Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2018
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor InhibitorsAtul Deodhar, Denis Poddubnyy, Cesar Pacheco-Tena, et al.
The New England Journal of Medicine|July 27, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Plos One|January 26, 2022
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysisGiulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Rheumatology (Oxford, England)|September 22, 2021
Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trialsMark C Genovese, Eduardo Mysler, Tetsuya Tomita, et al.
Annals of the Rheumatic Diseases|March 10, 2022
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialMaria C Cid, Sebastian H Unizony, Daniel Blockmans, et al.
Journal of Clinical Medicine|June 2, 2021
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological TherapyElena Bolletta, Marco Coassin, Danilo Iannetta, et al.
Journal of Personalized Medicine|December 23, 2022
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast StudyChrystel Isca, Amelia Spinella, Angela Toss, et al.
Ocular Immunology and Inflammation|October 5, 2020
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular SarcoidosisElena Bolletta, Valentina Mastrofilippo, Alessandro Invernizzi, et al.
Rheumatology (Oxford, England)|May 26, 2020
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trialsMark C Genovese, Eduardo Mysler, Tetsuya Tomita, et al.
Frontiers in Oncology|November 7, 2022
Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL studySerena Di Cosimo, Maria Teresa Lupo-Stanghellini, Massimo Costantini, et al.
Pageof 63